These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14729805)

  • 21. Microvascular endothelial dysfunction during cardiopulmonary bypass in surgery for correction of cyanotic and acyanotic congenital heart disease.
    Ugenti V; Romano AC; Tibirica E
    Microvasc Res; 2018 Nov; 120():55-58. PubMed ID: 29958862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of sevoflurane anesthesia and cardiopulmonary bypass on renal function in cyanotic and acyanotic children undergoing cardiac surgery.
    Oc B; Akinci SB; Kanbak M; Satana E; Celebioglu B; Aypar U
    Ren Fail; 2012; 34(2):135-41. PubMed ID: 22150502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary arteriovenous fistula for the palliation of complex cyanotic congenital heart disease: is it an effective tool?
    Quiñonez LG; Brown ML; Dearani JA; Burkhart HM; Puga FJ
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):188-92. PubMed ID: 20619423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases.
    Trojnarska O; Gwizdala A; Katarzynski S; Katarzynska A; Oko-Sarnowska Z; Grajek S; Kramer L
    Int J Cardiol; 2010 Mar; 139(3):241-7. PubMed ID: 19042041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extramedullary hematopoiesis causing paraparesis in congenital cyanotic heart disease.
    Taylor CL; Maynard F; Liebman J; Hlavin ML
    Neurology; 1998 Aug; 51(2):636-7. PubMed ID: 9710059
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiopulmonary stress testing in children who have had congenital heart disease surgery. Physical exercise recommendations during school hours].
    Serra-Grima R; Doñate M; Borrás X; Rissech M; Puig T; Albert DC; Bartrons J; Gran F; Manso B; Ferrer Q; Girona J; Casaldáliga J; Subirana M
    Rev Esp Cardiol; 2011 Sep; 64(9):780-7. PubMed ID: 21775042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional hyposplenia in cyanotic congenital heart disease.
    Pearson HA; Schiebler GL; Spencer RP
    Pediatrics; 1971 Aug; 48(2):277-80. PubMed ID: 5560621
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiorespiratory testing: anaerobic threshold/respiratory threshold.
    Washington RL
    Pediatr Cardiol; 1999; 20(1):12-5; discussion 16. PubMed ID: 9861065
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hematopoietic system in cyanotic congenital heart disease].
    Lewandowska K; Rachocka J
    Pol Tyg Lek; 1968 Dec; 23(51):1984-6. PubMed ID: 4883798
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of ghrelin and insulin-like growth factor-1 in immature piglet model of chronic cyanotic congenital heart defects with decreased pulmonary blood flow.
    Wang D; Liu YL; Lü XD; Zhu YB; Ling F; Liu AJ; Li G; Xu YL
    Chin Med J (Engl); 2011 Aug; 124(15):2354-60. PubMed ID: 21933568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The hematopoietic system in patients with congenital cyanotic heart disease].
    Pellar J
    Wiad Lek; 1968 Oct; 21(20):1811-4. PubMed ID: 4883228
    [No Abstract]   [Full Text] [Related]  

  • 32. Arterial stiffness and arterial function in adult cyanotic patients with congenital heart disease.
    Trojnarska O; Szczepaniak-Chicheł L; Gabriel M; Bartczak-Rutkowska A; Rupa-Matysek J; Tykarski A; Grajek S
    J Cardiol; 2017 Jul; 70(1):62-67. PubMed ID: 27756510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise capacity in children and adolescents with corrected congenital heart disease.
    Feltez G; Coronel CC; Pellanda LC; Lukrafka JL
    Pediatr Cardiol; 2015 Jun; 36(5):1075-82. PubMed ID: 25808364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro.
    Hamada H; Ebata R; Higashi K; Tateno S; Niwa K; Honda T; Yasukawa K; Terai M
    Int J Cardiol; 2007 Aug; 120(1):66-71. PubMed ID: 17126928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and pulmonary vascular endothelial growth factor/receptors and haemodynamic measurements in cyanotic congenital heart disease with decreased pulmonary blood flow.
    Tolunay I; Tunaoglu S; Akyürek N; Halid V; Olgunturk R; Kula S
    Cardiol Young; 2011 Dec; 21(6):608-15. PubMed ID: 21774842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How should I treat an adult with unoperated complex cyanotic heart disease with severe pulmonary stenosis?
    Nagel B; Maier R; Kaemmerer H; Koestenberger M; Gamillscheg A; Hess J; Bogers AJ; Witsenburg M; Hofmann M; Hübler M
    EuroIntervention; 2014 Jun; 10(2):289-92. PubMed ID: 24952064
    [No Abstract]   [Full Text] [Related]  

  • 37. Care of the adult with cyanotic congenital heart disease.
    Miner PD; Canobbio MM
    Nurs Clin North Am; 1994 Jun; 29(2):249-67. PubMed ID: 7515491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of pulmonary artery pressure in cyanotic heart disease using selective coronary artery cannulation techniques.
    Dillon JC
    Br Heart J; 1982 Nov; 48(5):504-6. PubMed ID: 7138715
    [No Abstract]   [Full Text] [Related]  

  • 39. Exercise intolerance in adults with congenital heart disease.
    Dimopoulos K; Diller GP; Piepoli MF; Gatzoulis MA
    Cardiol Clin; 2006 Nov; 24(4):641-60, vii. PubMed ID: 17098517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction to the physiology of congenital heart disease with cyanosis.
    Verheugt AP
    Radiol Clin Biol; 1970; 39(2):67-74. PubMed ID: 5426157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.